Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
44 Cards in this Set
- Front
- Back
relation of gout with hyperuricemia
|
gout is always preceeded by hyperuricemia, but hyperuricemia does not always lead to gout
|
|
transient attacks of gout initiated by?
|
crystallization of urates in and around joints
|
|
podagra
|
gout of greater toe/ most common joint affected
|
|
tophi
|
lg aggregates of urate crystals and the surrounding inflammatory response
|
|
Lesch-Nyhan syndrome
|
x-linked recessive d/o affecting only males in which HGPRT(required for salvage pathway) is totally absent
|
|
four stages of gout
|
1. asymptomatic hyperuricemia
2. acute gouty arthritis 3. intercritical gout 4. chronic tophaceous gout |
|
renal manifestations of gout
|
-HTN
-renal colic(uric acid nephrolithiasis in 10-25% -chronic gouty nephropathy(20% die of renal failure) |
|
MOA of allopurinol and febuxostat
|
block synthesis of uric acid and xanthine oxidase inhibitor
|
|
MOA of probenecid
|
increase uric acid excretion with a uricosuric agent
|
|
indications for pegloticase
|
chronic gout refractory to conventional therapy
|
|
colchicine
|
blocks entry of leukocytes into affected joints with microtubule disrupting agent--used to limit inflammation
|
|
tx of pain and inflammation of gout
|
-NSAIDs are effective @ inflammatory doses
-steroids can be given orally or by interarticular injection |
|
ASA and gout
|
contraindicated since salicylate competitively inhibits the active tubular secretion of urate, causing net urate retention
|
|
Acid urine promotes urate crystallization, therefore tx by?
|
intaining an alkaline urine with liberal fluid intake and sodium bicarbonate; continue until serum uric acid normalizes and tophi disappear
|
|
MOA of uricosuric agents
|
block active reabsorption(normally 80% reabsorbed) and enhance urinary uric acid excretion
|
|
Probenecid (uricosuric agent)
MOA |
-inhibits tubular reabsorption of urate, increases excretion and decreases serum levels
|
|
what is meant by probenecid causing "mobilization"
|
retards urate depostion and promotes reabsorption of urate deposits
|
|
Probenecid dosing
|
-initiate with small doses to avoid dumping large amts of urate into urine and possible stone formation
-maintain adequate hydration and alkalinize the urine |
|
Probenecid is indicated for tx of gout in pts who have no hx of?
|
nephrolithiasis
|
|
DI of probenecid
|
-anionic form may competitively inhibit the active tubular secretion of other organic acids
-beneficial interaction with beta lactams |
|
probenecid pt info
|
-avoid ASA
-may take with food or antacid for GI upset -drink 6-8 full glasses per day to prevent ddevelopment of kidney stones -must take continuouslyfor therapeutic effect |
|
allopurinol
|
xanthine oxidase inhibitor--decrease production of uric acid without affecting synthesis of vital purines
|
|
oxipurinol
|
active metabolite of allopurinol
|
|
allopurinol warnings/ADR
|
--allergic skin rash/severe hypersensitivity rxn
--avoid in acute gout attacks due to mobilization/can give maintenance doses of colchicine prophylactically -fluid intake >/=2L required to prevent acid urine |
|
allopurinol pt info
|
-take with food or milk
-drink 10-12glasses of fluid q day -avoid agents which acidify the urine |
|
Febuxostat
|
selective nonpurine xanthine oxidase inhibitor
|
|
indication for febuxostat
|
chronic management of hyperuricemia in gout pts
|
|
Febuxostat
1. DI 2. ADR |
1.DI with meds metabolized by XO
2. gout flares at beginning of tx, use prophylactic therapy of NSAIDs or colchicine |
|
Pegloticase
|
recombinant polyethylene glycol(PEG)-modified mammalian uricase(urate oxidase)
-XO inhibitor |
|
Pegloticase MOA
|
oxidation of uric acid to allantoin (water soluble purine metabolite)resulting in lower serum uric acid levels
|
|
Peloticase indications
|
chronic gout refractory to conventional therapy in adults
|
|
Pegloticase Boxed Warning
|
for infusion-related and anaphylactic rxns;
-premedicate with antihistamines and corticosteroids -prophylactic NSAIDs or colchicine starting 1 wk prior to 1st infusion an dcontinue 6 mo to prevent gout flares |
|
contraindication of Pegloticase
|
G6PD deficiency=> increases hemolysis and methemoglobinemia
|
|
Cochicine MOA
|
binds to tubulin preventing polymerization--inhibition of leukocyte migration, decreased phagocytosis and diminished inflammatory response to deposited crystals, and blocks cell division by binding to mitotic spindles
|
|
Colchicine FDA safety concerns
|
--cases of fatal toxicity at therapeutic doses with other meds
-substantiallly lower dose as effective , but fewer ADR |
|
Colchicine warnings
|
-do not give P-glycoprotein(Pgp) inhibitors or strong 3A4 inhibitors to pts with renal or hepatic impairment who are on colchicine
|
|
Colchicine indications
|
used for relief of acute gout attacks and for regular prophylactic use between attacks
-often effective in aborting an attack if taken at first sign of discomfort |
|
Colchicine ADR
|
severe GI effects: N/V/D and abdominal pain
-diarrhea most common and dose limiting effect -can tx diarrhea with opiates |
|
tx of osteoarthritis is _______
|
empiric and should be directed at symptom relief
|
|
acetominophen for tx of osteoarthritis
|
-effective/recommended as initial therapy at max adult doses
-max daily dose: <4g/d |
|
NSAIDs in tx of osteoarthritis
|
-used if any inflammatory component is present or if pain relief from acetominophen is inadequate
|
|
Antidepressants in tx of fibromyalgia
|
-dual mechanism antidepressants block reuptake of both NE and 5HT
|
|
Antidepressants approved for use in fibromyalgia
|
-duloxetine(Cymbalta)
-milnacipran(Savella) |
|
pregabalin(Lyrica) in tx of fibromyalgia
|
-anticonvulsant
-1st FDA approved drug for fibromyalgia |